Patents for A61P 35 - Antineoplastic agents (221,099)
01/2006
01/26/2006CA2570887A1 Tumor treatment
01/26/2006CA2570817A1 Azaindoles modulating c-kit activity and uses therefor
01/26/2006CA2570780A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
01/26/2006CA2570698A1 Bis(thio-hydrazide amide) salts for treatment of cancers
01/26/2006CA2570471A1 Use of apo2l receptor agonists and nk cells or nk cell activators
01/26/2006CA2568534A1 Vegf inhibitors for the treatment of malignant pleural effusion
01/26/2006CA2567569A1 Selective inhibitors against cdk4 and cdk6 having aminothiazole skeleton
01/25/2006EP1619250A1 WSX receptor and ligands
01/25/2006EP1619207A2 HLA-A2.1 binding peptides derived from HCV and their uses
01/25/2006EP1619203A1 Galectin 9-inducing factor
01/25/2006EP1619202A2 immunotherapeutic methods using epitopes of wt-1 and gata-1
01/25/2006EP1619194A2 Triazaspiro[5.5]undecane derivatives and pharmaceutical composition comprising the same as active ingredient
01/25/2006EP1619193A1 Spiropiperidine compound and medicinal use thereof
01/25/2006EP1619192A2 Aryl fused azapolycyclic compounds
01/25/2006EP1618898A2 Methods for regulating angiogenesis
01/25/2006EP1618897A1 Lipid membrane structure containing anti-mt-mmp monoclonal antibody
01/25/2006EP1618892A1 Instrument for inducing cytokine and method of inducing cytokine
01/25/2006EP1618890A1 Use of antibodies in a very low dose for the vaccination against cancer
01/25/2006EP1618888A1 Production of human papillomavirus capsid protein and virus-like particles
01/25/2006EP1618884A1 Instrument for inducing cytokine and method of inducing cytokine
01/25/2006EP1618879A1 Injectable formulations of taxanes for cad treatment
01/25/2006EP1618192A1 Human alkaline sphingomyelinase and use thereof
01/25/2006EP1618134A2 Tissue factor antibodies and uses thereof
01/25/2006EP1618117A1 Tumor selective and biodegradable polyphosphazene-platinum(ii) conjugate antitumor agent, and preparation method thereof
01/25/2006EP1618102A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
01/25/2006EP1618098A2 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
01/25/2006EP1617876A1 Thorium-227 for use in radiotherapy of soft tissue disease
01/25/2006EP1617873A2 Mitomycin conjugates cleavable by thiols
01/25/2006EP1617859A1 Methods and compositions using gonadotropin hormone releasing hormone
01/25/2006EP1617856A2 Somatostatin-dopamine chimeric analogs
01/25/2006EP1617845A2 Compositions and methods for induction of opioid receptors
01/25/2006EP1617810A2 Methods for preparation and use of 1alpha,24(s)-dihydroxyvitamin d2
01/25/2006EP1617807A2 Substituted 1,4-diazepines and uses thereof
01/25/2006EP1392241A4 System for osmotic delivery of pharmaceutically active agents
01/25/2006EP1255746B1 Oxy- and amino-substituted tetrahydrofuryl derivatives with antimour activity
01/25/2006EP1235825B1 Novel benzoimidazole derivatives useful as antiproliferative agents
01/25/2006EP1224189B1 Condensed dihydroquinolinone derivatives for inhibiting mrp1
01/25/2006EP1212318B1 Substituted indolinones as tyrosine kinase inhibitors
01/25/2006EP1144650B1 Goodpasture antigen binding protein
01/25/2006EP1115408B1 Oxihumic acid and its use in the treatment of various conditions
01/25/2006EP0980427B1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes
01/25/2006CN1726218A Pyrrolopyrimidine derivatives
01/25/2006CN1726217A Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
01/25/2006CN1726213A Imidazoquinoline derivatives as adenosine A3 receptor ligands
01/25/2006CN1726204A Enantiomers of thiophene hydroxamic acid derivatives and their use as hdac inhibitors
01/25/2006CN1726198A Compounds, compositions, and methods
01/25/2006CN1726194A Novel compounds
01/25/2006CN1726023A Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders
01/25/2006CN1726022A Pregabalin derivatives for the treatment of fibromyalgia and other disorders and its derivitive
01/25/2006CN1726021A Alpha2delta ligands for the treatment of sexual dysfunction
01/25/2006CN1726015A Alpha2delta ligands for different pharmaceutical uses
01/25/2006CN1724683A Method of preparing peptide having trypsin inhibition activity by using complex enzyme enzymolysis oyster
01/25/2006CN1724666A Immune tbid gene and its coded protein and application
01/25/2006CN1724561A Series peptide for promoting proliferation of bone marrow karyota and bone marrow substrate cell and its application
01/25/2006CN1724558A Series peptide for inhibiting growth of cancer cell and bone marrow karyocyte and its application
01/25/2006CN1724544A Extraction of plasmalogen kind anticancer medicine from animal liver
01/25/2006CN1724529A High purity cnidicin and its preparation method and medicinal composition using said compound as active component
01/25/2006CN1724521A New quinazoline hind derivative, medicinal composition containing same and their use
01/25/2006CN1724520A Indenoindole ketone kind compound, its preparation method and use
01/25/2006CN1724516A Natural and synthetic isothiocyanate kind compound and its application in treating and preventing cancer
01/25/2006CN1724067A Application of lumbricus plasmin component for anti-tumour
01/25/2006CN1724066A Controlled release composition and method of producing the same
01/25/2006CN1724063A Method for producing turmeric stable prepn.
01/25/2006CN1724015A Recipe of medicine for anti-cancer and analgesis, and its prepn. method
01/25/2006CN1723984A Medicine for inducing cells to die, and its application
01/25/2006CN1723979A Injection contg.codonopsis pilosule and Radix astragali for strengthening the body resistance, and its prodn. process
01/25/2006CN1723958A Method for extracting spore oil from exosporium-broken spore of glossy ganoderma
01/25/2006CN1723956A Medicine for treating chronic gastritis and gastric carcinoma, and its prepn. method
01/25/2006CN1723953A Herb medicine
01/25/2006CN1723951A Extractive from Gypsophila oldhamiana Miq with anti-cancer activity, prepn. method and application therewith
01/25/2006CN1723949A Medicine for treating tumor
01/25/2006CN1723925A Pills for anti-cancer and detumescence
01/25/2006CN1723906A Cucurbitacine liposome and its prepn. method
01/25/2006CN1723904A pH sensing controlable nanometer particle carried with 5-Fu and its prepn. method
01/25/2006CN1723903A Matrix metalloproteinase and tumor necrosis factor inhibitors
01/25/2006CN1723900A Stephanine soft capsule, and its prepn. method
01/25/2006CN1723889A Slow-releasing micro-balls of demethyl cantharidine, and its prepn. method
01/25/2006CN1723887A Paclitaxel injection, and its prepn. method
01/25/2006CN1238516C Production of polysaccharide protein by deep fermentation of hysteriales for anticancer
01/25/2006CN1238504C Tumour related gene and use thereof
01/25/2006CN1238365C EB virus antisense oligomeric deoxynucleotide and its application
01/25/2006CN1238341C 1 Alpha-hydroxy-25-ene-vitamin D, analogs and use thereof
01/25/2006CN1238052C Obtaining of cell growth inhibiting polypeptide and its usage
01/25/2006CN1238023C Anticancer medicine
01/25/2006CN1238022C Anticancer reversal powder
01/25/2006CN1238006C Medicament for treating pulmonary neoplasm, asthma and trachitis and method for making same
01/25/2006CN1237985C Traditional Chinese medicine injection for treating tumor and preparation process thereof
01/25/2006CN1237984C Freezing-drying powder injection preparation for anticancer made of Chinese herb medicines and method of making same
01/25/2006CN1237974C Ursolic acid dripping pills and its preparation process
01/25/2006CN1237968C Methods for inhibiting proliferation and inducing apoptosis of cancer cells
01/25/2006CN1237957C Hypocrellin liposome solid powder preparaton and producing method
01/24/2006US6989452 Anticancer agents
01/24/2006US6989450 Aldol condensation of a ketonic compound containing free or protected alcohol group with a acid or or metallic salt group containing compound to form intermediate, performing macrolactonizing of the intermediate
01/24/2006US6989435 Compounds and methods to inhibit or augment an inflammatory response
01/24/2006US6989402 Thyroid receptor ligands and method II
01/24/2006US6989398 Benzanilides as potassium channel openers
01/24/2006US6989396 Anticancer agents; modulating glycoprotein
01/24/2006US6989390 of carboxylic acids, such as maleic or glycolic acid; treating breast cancer, colon cancer, lung cancer, renal cancer and prostate cancer.
01/24/2006US6989388 Antitumor agents; anticancer agents; antiischemic agents; antiinflamamtory agents
01/24/2006US6989387 Topoisomerase inhibitors; use treating cancer, as antifungal agent, treating bacterial infections; compounds based on Dibenzo[c,h][1,6]Naphthyridine ring with at least one nitro or amine-based substitution